SCHEMBL4230013

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

	Compound	similarity	top predicted	shared targets
	SCHEMBL4236887	0.89	MAPT (0.49)	ARCHEK2MAPTPKMLMNA
	SCHEMBL4296468	0.86	AR (0.51)	PTGS2ARPDE4BPDE4D
	SCHEMBL4233150	0.82	AR (0.60)	ARMAPTLMNARAB9ASLC34A1
	SCHEMBL4234584	0.81	AR (0.47)	ARSLC34A1ALOX15HSD17B10
	SCHEMBL4237455	0.79	AR (0.52)	ARRAB9ASLC34A1MAOBSMN1; SMN2
	SCHEMBL4237759	0.79	AR (0.56)	ARMAPTLMNARAB9ASLC34A1
	SCHEMBL4305348	0.78	PTGS1 (0.48)	PTGS2ARMAPTLMNASLC34A1
	SCHEMBL4230109	0.77	AR (0.56)	ARSLC34A1
	SCHEMBL4232212	0.77	AR (0.50)	ARCHRNB2CHRNA4SLC34A1CYP19A1
	SCHEMBL4241563	0.77	AR (0.52)	ARSLC34A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.